SEI Investments’s Sana Biotechnology SANA Stock Holding History

SEI Investments’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$61.7K	Hold	17,668	–	–	﹤0.01%	3225
2026 Q1	$50.9K	Hold	17,668	–	–	﹤0.01%	3171
2025 Q4	$71.9K	Hold	17,668	–	–	﹤0.01%	3048
2025 Q3	$62.7K	Hold	17,668	–	–	﹤0.01%	2761
2025 Q2	$48.2K	Hold	17,668	–	–	﹤0.01%	2755
2025 Q1	$29.7K	Hold	17,668	–	–	﹤0.01%	2720
2024 Q4	$28.8K	Hold	17,668	–	–	﹤0.01%	2700
2024 Q3	$73.5K	Buy	+17,668	New	+$92.8K	﹤0.01%	2599

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

SEI Investments's SANA Position: Q2 2026 in Review

SEI Investments held its Sana Biotechnology (SANA) position steady in Q2 2026 at 17,668 shares worth $61.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3225.

SEI Investments first reported a position in SANA in Q3 2024 and has held it in 8 quarters since. The position peaked at $73.5K in Q3 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

SEI Investments held 17,668 shares of Sana Biotechnology worth $61.7K as of Q2 2026.
SEI Investments left its Sana Biotechnology share count unchanged in Q2 2026.
Sana Biotechnology made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3225 holding.
SEI Investments first reported a position in Sana Biotechnology in Q3 2024 and has held it in 8 quarters since.
SEI Investments's Sana Biotechnology position peaked at $73.5K in Q3 2024.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.